Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM

Name: Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
License: Public Domain

GlaxoSmithKline

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

multiple myeloma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 321588
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.